Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery
Phase of Trial: Phase IV
Latest Information Update: 19 May 2018
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetes mellitus; Hyperglycaemia
- Focus Therapeutic Use
- 26 Sep 2016 Status changed from recruiting to discontinued.
- 20 Apr 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 20 Apr 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.